![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
Allergan |
---|---|
Information provided by: | Allergan |
ClinicalTrials.gov Identifier: | NCT00833235 |
This is a multi-center, prospective, controlled, observational study of the natural history of patients with dry eye disease.
Condition |
---|
Dry Eye |
Study Type: | Observational |
Study Design: | Case Control, Prospective |
Tear collection
Estimated Enrollment: | 250 |
Study Start Date: | February 2009 |
Estimated Study Completion Date: | February 2013 |
Estimated Primary Completion Date: | February 2013 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
A
Patients with dry eye
|
B
Patients with no history of dry eye
|
Ages Eligible for Study: | 40 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
At least 200 dry eye patients (with at least 40% of patients with elevated biomarkers for ocular surface inflammation) will be enrolled at approximately 15-20 sites. Approximately 40-50 patients will be enrolled in the control group.
Inclusion Criteria:
Exclusion Criteria:
Contact: Allergan Inc | clinicaltrials@allergan.com |
United States, Maryland | |
Baltimore, Maryland, United States |
Study Director: | Medical Director | Allergan |
Responsible Party: | Allergan, Inc. ( Vice President Medical Affairs ) |
Study ID Numbers: | MA-RES-O8-001 |
Study First Received: | January 30, 2009 |
Last Updated: | January 30, 2009 |
ClinicalTrials.gov Identifier: | NCT00833235 History of Changes |
Health Authority: | United States: Institutional Review Board |